(Q62814189)
Statements
RV 507: A Phase I Open-Label, Dose-Escalation Clinical Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Marburg Chimpanzee Adenovirus Vector Vaccine, VRC-MARADC087-00-VP (cAd3-Marburg), in Healthy Adults (English)
0 references
10 October 2018
0 references
July 2019
0 references
40
0 references
18 year
0 references
50 year
0 references